Biotechnological and Biosimilar Drugs and Facilities
An article by Namık Yener. It explains how biotechnological drugs are produced, what biosimilar drugs are, and why the expiry of many biotechnology patents in the next decade will increase competition. It also discusses the requirements for biotechnological production facilities. This post is an English summary. The full text is available in Turkish: read the […]